- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 18.1M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 17.46M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 16.24M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $4.27M |
| Capex | Q1 2026 · Mar 31, 2025 | $1.08M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $30.87M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $37.69M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $135.18M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $81.71M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $983.14M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $233.51M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.7B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.35B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $11.28B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.45B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $12.98B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $9.81B |
| Total Assets | Q1 2026 · Mar 31, 2025 | $9.89B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $2.39 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $2.60 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $2.40 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $2.61 |
| Net Income | Q1 2026 · Mar 31, 2026 | $41.69M |
| Net Income | Q1 2026 · Mar 31, 2025 | $42.16M |
| Revenue | Q1 2026 · Mar 31, 2026 | $188.51M |
| Revenue | Q1 2026 · Mar 31, 2025 | $157.95M |